What is Alpha-Gal Syndrome?

Alpha-Gal Syndrome (AGS) is an allergic condition triggered by the bite of a Lone Star tick. It causes allergic reactions to galactose-alpha-1,3-galactose (alpha-gal), a sugar molecule found in most mammals. Symptoms typically appear 3-6 hours after eating red meat, pork, or lamb, and can range from hives to life-threatening anaphylaxis. According to the CDC, over 450,000 Americans may have developed AGS since 2010.

What foods should Alpha-Gal patients avoid?

Alpha-Gal patients must avoid all mammalian meat including beef, pork, lamb, venison, and bison. Many also react to mammalian by-products like gelatin (found in gummy vitamins and gel capsules), dairy products, and ingredients derived from mammals such as lard, tallow, and carrageenan. Safe alternatives include poultry (chicken, turkey, duck), fish, seafood, eggs, and all plant-based foods.

What medications are safe for Alpha-Gal Syndrome?

Many medications contain hidden mammalian ingredients. Gel capsules and softgels often contain bovine or porcine gelatin. Safe alternatives include tablets, caplets, liquids, and capsules made with vegetable-based HPMC. Always check inactive ingredients for gelatin, magnesium stearate (usually plant-derived in US), lactose, and stearic acid. VectorShield helps patients identify safe medication alternatives.

What are the 4 sensitivity levels of Alpha-Gal Syndrome?

Alpha-Gal sensitivity varies by patient: Level 1 (Mild, ~40%) - react only to mammalian meat; Level 2 (Moderate, ~30%) - also react to gelatin products; Level 3 (Significant, ~20%) - also react to dairy products; Level 4 (Severe, ~10%) - react to trace amounts and cross-contamination, sometimes called 'super reactors'. Sensitivity can change over time, especially with additional tick bites.

Can Alpha-Gal Syndrome be cured?

There is currently no cure for Alpha-Gal Syndrome, but many patients see improvement over time if they avoid additional tick bites. Some patients report tolerance returning after 1-5 years of strict avoidance and no new tick exposures. However, a single new tick bite can restart or worsen the condition. Management focuses on strict avoidance of trigger foods and carrying emergency medication like epinephrine.

Advancing AGS Research

Help Us Understand Alpha-Gal

VectorShield is partnering with researchers to advance our understanding of Alpha-Gal Syndrome. Your anonymized data can help others.

How Your Data Helps

When you take our sensitivity quiz or use the app, your anonymized data contributes to a growing dataset that researchers can use to better understand AGS.

📊

Pattern Recognition

Identifying common triggers and reaction patterns across sensitivity levels

🔬

Treatment Research

Supporting studies on potential treatments and tolerance recovery

🗺️

Epidemiology

Understanding AGS prevalence and geographic distribution

Active Research Areas

Sensitivity Patterns

Ongoing

Understanding why some patients react to dairy while others don't

Recovery Factors

Planned

Identifying factors that help patients regain tolerance over time

Medication Safety

Ongoing

Building a comprehensive database of safe medication alternatives

Geographic Distribution

Planned

Mapping AGS prevalence and tick species correlation

Key Publications

Foundational research that defines our understanding of Alpha-Gal Syndrome

Tick bites and red meat allergy

2011

Commins SP, James HR, Kelly LA, et al.

Establishing the causal link between tick bites and the development of alpha-gal IgE antibodies leading to red meat allergy.

Curr Opin Allergy Clin ImmunolPubMed: 21772139

Diagnosis & management of alpha-gal syndrome: lessons from 2,500 patients

2020

Commins SP

Comprehensive clinical insights from managing over 2,500 AGS patients, covering diagnosis, co-factors, and treatment approaches.

Expert Rev Clin ImmunolPubMed: 32571129

Tick-induced allergies: mammalian meat allergy, tick anaphylaxis and their significance

2015

Van Nunen SA

Overview of tick-induced allergic conditions including AGS, with emphasis on the Australian paralysis tick and global significance.

Asia Pac AllergyPubMed: 25553259

The evolving story of alpha-gal syndrome

2023

Platts-Mills TAE, Commins SP, Biedermann T, et al.

Comprehensive review of AGS pathophysiology, expanding geographic range, and emerging clinical management strategies.

J Allergy Clin ImmunolPubMed: 37116679

Search All AGS Publications on PubMed

Active Clinical Trials

Researchers are actively studying Alpha-Gal Syndrome. Clinical trials explore new diagnostic tools, treatment approaches, and desensitization protocols.

Browse AGS Trials on ClinicalTrials.gov Recruiting Trials Only

Want to Participate?

Take our sensitivity quiz to contribute your data to AGS research. All data is anonymized and used only for research purposes.

Take the Quiz Learn About AGS

For Researchers

Are you conducting research on Alpha-Gal Syndrome? We may be able to provide anonymized, aggregated data to support your work.

Contact Our Research Team

Stay Updated on AGS Research

Get updates on new studies, research findings, and ways to participate.